F45D9

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameF45D9
Drug Alias NameAnti-Fas Receptor mAb (IMED)F45D9
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionApoptosis-mediating surface antigen FAS inhibitors
TargetsApoptosis-mediating surface antigen FAS
Therapy Area/IndicationsGraft vs Host DiseaseReperfusion InjuryNeoplasms +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIMED AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIMED AB
Active IndicationsN/A
Inactive IndicationsGraft vs Host DiseaseReperfusion InjuryNeoplasms +[4] 

Other Information

ATC CodeN/A
Related LinksN/A